ER Stress Inhibits mTORC2 and Akt Signaling Through GSK-3β–Mediated Phosphorylation of Rictor

Cellular stress attenuates growth factor signaling through a phosphorylation event that blocks substrate access to the kinase complex mTORC2. No Access During Stressful Times Under conditions of cellular stress, cells tend to halt anabolic processes, such as cell growth and proliferation, to conserve resources. mTORC2 (mammalian target of rapamycin complex 2), which mediates its effects through activation of the kinase Akt, is a key signaling complex that promotes anabolic processes. Chen et al. investigated the mechanisms by which mTORC2 activity is inhibited by endoplasmic reticulum (ER) stress. They found that glycogen synthase kinase–3β (GSK-3β), which is activated by ER stress, phosphorylated rictor, a component of mTORC2 that helps to determine substrate specificity for the complex. This phosphorylation event decreased binding of Akt to mTORC2, resulting in reduced activation of Akt and cell proliferation. Furthermore, transformed cells expressing a mutant form of rictor lacking the GSK-3β phosphorylation site formed larger tumors in mice than did those expressing wild-type rictor or a rictor mutant that mimicked a constitutively phosphorylated form. These results define a pathway by which mTORC2 and Akt signaling can be attenuated by cellular stress and provide a potential therapeutic target for limiting cell proliferation (such as in cancer). In response to environmental cues, cells coordinate a balance between anabolic and catabolic pathways. In eukaryotes, growth factors promote anabolic processes and stimulate cell growth, proliferation, and survival through activation of the phosphoinositide 3-kinase (PI3K)–Akt pathway. Akt-mediated phosphorylation of glycogen synthase kinase–3β (GSK-3β) inhibits its enzymatic activity, thereby stimulating glycogen synthesis. We show that GSK-3β itself inhibits Akt by controlling the mammalian target of rapamycin complex 2 (mTORC2), a key activating kinase for Akt. We found that during cellular stress, GSK-3β phosphorylated the mTORC2 component rictor at serine-1235, a modification that interfered with the binding of Akt to mTORC2. The inhibitory effect of GSK-3β on mTORC2-Akt signaling and cell proliferation was eliminated by blocking phosphorylation of rictor at serine-1235. Thus, in response to cellular stress, GSK-3β restrains mTORC2-Akt signaling by specifically phosphorylating rictor, thereby balancing the activities of GSK-3β and Akt, two opposing players in glucose metabolism.

[1]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[2]  Nam‐Gyun Kim,et al.  Regulation of protein stability by GSK3 mediated phosphorylation , 2009, Cell cycle.

[3]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[4]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[5]  R. Kaufman,et al.  Identification and characterization of endoplasmic reticulum stress-induced apoptosis in vivo. , 2008, Methods in enzymology.

[6]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[7]  Nicole Cloonan,et al.  Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. , 2007, Cellular signalling.

[8]  F. McCormick,et al.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.

[9]  M. Permutt,et al.  Genetic Deficiency of Glycogen Synthase Kinase-3β Corrects Diabetes in Mouse Models of Insulin Resistance , 2008, PLoS biology.

[10]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[11]  J. Asara,et al.  Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.

[12]  J. Woodgett,et al.  Modulation of the glycogen synthase kinase‐3 family by tyrosine phosphorylation. , 1993, The EMBO journal.

[13]  Han You,et al.  Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. , 2006, Genes & development.

[14]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[15]  Kirk W. Johnson,et al.  Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. , 2003, Diabetes.

[16]  D. Sabatini,et al.  Structure of S6 Kinase 1 Determines whether Raptor-mTOR or Rictor-mTOR Phosphorylates Its Hydrophobic Motif Site*♦ , 2005, Journal of Biological Chemistry.

[17]  A. Depaoli-Roach,et al.  Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. , 1994, The Journal of biological chemistry.

[18]  D. Onichtchouk,et al.  Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells* , 2007, Journal of Biological Chemistry.

[19]  A. Linstedt,et al.  Osmotically induced cell volume changes alter anterograde and retrograde transport, Golgi structure, and COPI dissociation. , 1999, Molecular biology of the cell.

[20]  D. Alessi,et al.  The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.

[21]  Hasmik Keshishian,et al.  Rictor Phosphorylation on the Thr-1135 Site Does Not Require Mammalian Target of Rapamycin Complex 2 , 2010, Molecular Cancer Research.

[22]  P. Greengard,et al.  Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. , 2004, Journal of medicinal chemistry.

[23]  V. Pantesco,et al.  Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch , 1993, Nature.

[24]  J. Woo,et al.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. , 2006, Developmental cell.

[25]  K. Inoki,et al.  Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. , 2006, Genes & development.

[26]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[27]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[28]  J. Downward,et al.  Rictor is a novel target of p70 S6 kinase-1 , 2010, Oncogene.

[29]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[30]  D. Green,et al.  GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. , 2004, Molecular cell.

[31]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[32]  David E. James,et al.  Regulated transport of the glucose transporter GLUT4 , 2002, Nature Reviews Molecular Cell Biology.

[33]  Wen-Chang Chang,et al.  Glycogen synthase kinase 3α and 3β have distinct functions during cardiogenesis of zebrafish embryo , 2007, BMC Developmental Biology.

[34]  Xin Lin,et al.  The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation , 2009, Science.

[35]  B. Hemmings,et al.  PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. , 2008, Molecular cell.

[36]  Michel Goedert,et al.  GSK3 inhibitors: development and therapeutic potential , 2004, Nature Reviews Drug Discovery.

[37]  Philippe P Roux,et al.  mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling , 2009, Molecular and Cellular Biology.

[38]  R. Jope,et al.  Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation* , 2002, The Journal of Biological Chemistry.

[39]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[40]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[41]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[42]  J. Blenis,et al.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.

[43]  M. Permutt,et al.  Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3beta in mouse insulinoma cells. , 2005, Diabetes.

[44]  D. Alessi,et al.  mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). , 2008, The Biochemical journal.

[45]  A. Ray,et al.  Glycogen synthase kinase 3: more than a namesake , 2009, British journal of pharmacology.